ivermectin - living meta-analysis of clinical studies

table network network 2

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID-19 mild to moderate	COVID-19 severe or critically

	COVID 19 hospitalized	COVID-19 mild to moderate	COVID-19 severe or critically
ivermectin	Gonzalez ...	Shahbaznejad Kirti I-TECH ... Babalola Mayer RIVET-COV ... Ahmed Chachar Chaccour Abd-Elsalam Bukhari Krolewiecki	Galan Galan Okumuş
ivermectin plus doxycycline	Hashim A	NCT04523831 ...

13 studies excluded by filtering options 1

6064	Glorial F, 2020	1	10	0		not a RCT	risk of bias not avaialble
6082	ICON, 2020	0	13	0	selection pending
6095	Camprubi, 2020	1	11	0		not a RCT	risk of bias not avaialble
6375	Cadegiani -Iver, 2020	2	99	0	excluded	not a RCT	risk of bias not avaialble
6381	Espitia-Hernandez, 2020	1	31	0		not a RCT	risk of bias not avaialble
6382	Khan, 2020	0	13	0	selection pending
6382	Khan, 2020	0	13	0	selection pending
6383	Soto-Becerra, 2020	0	12	2	selection pending
6383	Soto-Becerra, 2020	0	12	2	selection pending
6384	Spoorthi, 2020	1	31	0		not a RCT	risk of bias not avaialble
6384	Spoorthi, 2020	1	31	0		not a RCT	risk of bias not avaialble
6625	Nasir, 2020	2	31	0	excluded	not a RCT	risk of bias not avaialble
7995	Hazan, 2021	2	32	0	excluded	not a RCT	risk of bias not avaialble